LEADER 01235nas  2200409-a 450 
001 996199213303316
005 20240413013123.0
035   $a(CKB)1000000000224336
035   $a(CONSER)--2004212918
035   $a(EXLCZ)991000000000224336
100   $a20040122b20042010  ---         a
101 0 $aeng
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aDrug formulary review
210   $aAtlanta, GA $cThomson American Health Consultants
215   $a1 online resource
311 08$aPrint version: Drug formulary review. 1548-2790 (DLC)  2004212918 (OCoLC)54067903 
531 0 $aDrug formul. rev.
606   $aDrug utilization$vPeriodicals
606   $aDrug Utilization
606   $aChemistry, Pharmaceutical
606   $aDrug utilization$2fast$3(OCoLC)fst00898740
608   $aPeriodical.
608   $aPeriodicals.$2fast
608   $aPeriodicals.$2lcgft
615  0$aDrug utilization
615 12$aDrug Utilization.
615 22$aChemistry, Pharmaceutical.
615  7$aDrug utilization.
676   $a615
906   $aJOURNAL
912   $a996199213303316
920   $aexl_impl conversion
996   $aDrug formulary review$92108349
997   $aUNISA